Ambrx Biopharma Cayman, Inc.

Delisted

CIK 1836056fmd_1GAT2PMX1137CHR17NT2JG7H35Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Jun 30, 2023, 9 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.